Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel developmental pluripotency associated 4 pseudogene (ENSG00000251296) is classified as a human pseudogene. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically arise from duplicated or retrotransposed genes that have acquired mutations rendering them inactive. This gene does not encode a functional protein, is not considered a druggable target, and has no known role in disease or therapy. As such, it is not relevant for drug development or as a biomarker. No drugs, mechanisms of action, or safety concerns are associated with this pseudogene. ENSG00000251296 is not a therapeutic target, is not a receptor or enzyme, and is not functionally relevant for clinical or pharmaceutical applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel developmental pluripotency associated 4 pseudogene.